Kura Oncology (KURA) Reports In-Line Q4 EPS

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.55), in-line with the analyst estimate of ($0.55).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• HSBC Raises S&P500 Target to 8,100
• BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform